- Report
- April 2023
- 80 Pages
France
From €1424EUR$1,500USD£1,201GBP
- Report
- April 2023
- 80 Pages
China
From €1424EUR$1,500USD£1,201GBP
- Report
- April 2023
- 80 Pages
Brazil
From €1424EUR$1,500USD£1,201GBP
- Report
- April 2023
- 80 Pages
Argentina
From €1424EUR$1,500USD£1,201GBP
- Report
- April 2023
- 180 Pages
Global
From €2373EUR$2,500USD£2,002GBP
- Report
- April 2023
- 100 Pages
Africa
From €1899EUR$2,000USD£1,602GBP
The Respiratory Disease Vaccine market is a subset of the larger Respiratory Drugs market. Vaccines are used to prevent the spread of respiratory diseases, such as influenza, pneumonia, and tuberculosis. Vaccines are typically administered to children and adults, and are often recommended for those at high risk of developing respiratory diseases. Vaccines are typically administered through injection, nasal spray, or oral drops.
The Respiratory Disease Vaccine market is highly competitive, with many companies offering a variety of vaccines. Companies in the market include Merck, GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. These companies are involved in the research, development, and production of vaccines for a variety of respiratory diseases. Additionally, many of these companies are involved in the distribution of vaccines to healthcare providers and pharmacies. Show Less Read more